SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2024October05Saturday

CRISPR helps brain stem cells regain youth in mice - Nature.com

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today - Yahoo Finance

He Jiankui, scientist known for gene-editing babies, is out of prison and ready to rejoin the science community - The Globe and Mail

Filament structure found to activate and regulate CRISPR-Cas 'protein scissors' - Phys.org

Two Nobel Prize winners want to cancel their own CRISPR patents in Europe - MIT Technology Review

Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb - STAT

From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution - The Scientist

Patients At Last Begin Receiving Vertex-CRISPR and Bluebird Sickle Cell Gene Therapies - BioSpace

Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal? - The Motley Fool

What Is CRISPR? - Livescience.com

Genetic Engineering: 2024October05Saturday

The great gene editing debate: can it be safe and ethical? - BBC.com

Maxine Singer obituary: biologist who shaped genetic engineering and fought discrimination - Nature.com

Michel Sadelain Appointed Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy - The Office of the President, Columbia University

Genetic Engineering Has Been Applied to Cheese Making: No Reason to Be Cheesed Off. - Office for Science and Society

The pros and cons of GMOs - The Week

What do people think about genetic engineering? A systematic review of questionnaire surveys before and after the introduction of CRISPR - Frontiers

Chinese researchers’ implant genetically modified brain cells for neuron growth - South China Morning Post

Genetic engineering was meant to save chestnut trees. Then there was a mistake. - The Washington Post

Scientists Say: Genetic Engineering - Science News Explores

How GMO Crops Impact Our World - FDA.gov

Gene Editing : 2024October05Saturday

How to make gene editing ethical - IAI

He Jiankui, scientist known for gene-editing babies, is out of prison and ready to rejoin the science community - The Globe and Mail

Enhancing The Tool Box For Crop Breeding Innovation - Forbes

Editas cashes in on portion of Vertex gene editing licensing agreement for $57M - Fierce Biotech

Space travel is dangerous. Could genetic testing and gene editing make it safer? - MIT Technology Review

The great gene editing debate: can it be safe and ethical? - BBC.com

From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution - The Scientist

An experimental census of retrons for DNA production and genome editing - Nature.com

Sickle cell gene therapies roll out slowly : Shots - Health News - NPR

Vision 10,000 Times Better: Gene Therapy Delivers Life-Changing Results - SciTechDaily

CRISPR Therapy : 2024October05Saturday

World-first therapy using donor cells sends autoimmune diseases into remission - Nature.com

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m - Pharmaceutical Technology

What is CRISPR? A bioengineer explains - Stanford University News

Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy - FiercePharma

News: CMN Weekly (4 October 2024) - Your Weekly CRISPR Medicine News - CRISPR Medicine News

Gene Editing Improves Vision in Some People With Inherited Blindness - Harvard Medical School

UK's NHS to roll out Vertex/CRISPR gene therapy for rare blood disorder - Reuters

Canada Approves Vertex and CRISPR Therapeutics’ Gene Therapy Casgevy for Sickle Cell Disease and TDT - CGTLive™

Vertex, CRISPR’s Casgevy Highlights Complex Path to Gene Therapy Profitability - BioSpace

7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money